Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus vs Prograf in Heart Transplant Recipients
NCT03373227Phase 2Completed
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Dec 2017
- Primary completion
- Dec 2023
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus in heart transplant rejection, Graft failure, sponsored by Baylor Scott & White Research Institute. Started Dec 2017; status: completed.
02
Drugs
tacrolimus
03
Conditions
heart transplant rejectionGraft failure
Beyond the preview
Go deeper on NCT03373227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03373227.